Jennifer DePry, DO, FAAD

Board Certified. Fellowship-Trained MOHS Surgeon

Dr. Jennifer DePry is a board-certified dermatologist and a fellowship trained Mohs micrographic surgeon. She enjoys the opportunity to provide general dermatology services, cosmetic procedures, and skin cancer surgery to patients of all ages and skin types.

She has a strong clinical and research interest in skin cancer, particularly among immunosuppressed patients such as those who have undergone organ or hematopoietic cell transplantation. Providing advanced surgical reconstruction after skin cancer surgery that allows her patients to heal well and feel happy about their appearances is one of the most rewarding aspects of her career. She also enjoys contributing to dermatology research efforts and serving as a guest reviewer for medical journals.

Dr. DePry takes a thoughtful, individualized approach to medicine and strives to address each person’s goals.

Training

Micrographic Surgery and Dermatologic Oncology Fellowship, University Hospitals Case Medical Center, Cleveland, OH
Academic Chief Resident Dermatology, Dermatology, University Hospitals Case Medical Center, Cleveland, OH
Dermatology Resident, Dermatology, University Hospitals Case Medical Center, Cleveland, OH
Transitional Year Internship, St. John Providence Health System, Southfield, MI
Doctor of Osteopathic Medicine, Kansas City University of Medicine and Biosciences, Kansas City, MO
Bachelor of Arts Neuroscience, Cum Laude, University of Southern California Los Angeles, CA

Board of Certification

Board Certified Dermatologist

Leadership roles

Secretary of the Nevada Society for Dermatology and Dermatologic Surgery
Nevada Representative for the American Academy of Dermatology Advisory Board

Professional Societies

Women’s Dermatologic Society
American Academy of Dermatology
American Society for Dermatologic Surgery
American Osteopathic College of Dermatology
American College of Mohs Surgery
American College of Phlebology
American Society for Laser Medicine and Surgery

Publications
Deng M, Higgins HW 2nd, Lesiak K, Decker AB, Regula CG, Stevenson ML, Raphael B, Depry J, Scott JF, Bangash H, Ochoa SA, Ibrahimi OA, Shafai A, Bordeaux JS, Carucci JA, Cook JL, Goldman GD, Rohrer TE, Lawrence N. Expertise in Head and Neck Cutaneous Reconstructive Surgery. Dermatol Surg. 2019 Jun;45(6):782-790.
Schmitt A, DePry J, Tsai S, Bordeaux J; Retrospective evaluation of the safety of large skin flap, large skin graft, and interpolation flap surgery in the outpatient setting. Dermatologic Surgery. Dermatol Surg. 2018 Dec;44(12):1537-1546
DePry JL, Mann M; Successful treatment of postoperative pain after Mohs micrographic surgery with onabotulinum toxin A. Dermatologic Surgery. 2017 Dec; 43(12): 1491-1494.
Vargas CR, DePry J, Lee BT, Bordeaux JS. The readability of online patient information about Mohs micrographic surgery. Dermatologic Surgery. 2016 Oct; 42(10): 1135-41.
DePry J, Vyas R, Lazarus H, Caimi P, Gerstenblith M, Bordeaux J; Cutaneous malignant neoplasms in hematopoietic cell transplant recipients: A systematic review. JAMA Dermatology. 2015 Jul; 151(7): 775-82.
Oyetakin-White P, DePry J, Bordeaux J; Multiple granular cell tumors. Journal of the American Academy of Dermatology. 2015 May; 72(5): Supplement 1, AB54-AB54.
DePry J, Brescoll J, Szczotka-Flynn L, Rambhatla P, Lim H, Cooper K; Phototherapy-related ophthalmologic disorders. Clinics in Dermatology. 2015 Mar-Apr; 33(2): 247-55.
Vyas R, Gotow E, DePry J, Lazarus H, Caimi P, Bordeaux J, Gerstenblith M; Multiple skin cancers in a patient within one year of allogeneic hematopoietic cell transplant for chronic lymphocytic leukemia. Clinical and Experimental Dermatology. 2015 Dec; 40(8): 927-9.
DePry J, Golding R, Szczotka-Flynn L, Dao H, Baron E, Cooper K; UVB-protective properties of contact lenses with intended use in photoresponsive eyelid dermatoses. Photodermatology, Photoimmunology & Photomedicine. 2013 Oct; 29(5): 253-60.
DePry J, Reed K, Cook-Norris R, Brewer J; Iatrogenic immunosuppression and cutaneous malignancy. Clinics in Dermatology. 2011 Nov-Dec; 29(6): 602-13.
Lynde C, Bruce A, Orividas L, Rogers R, DePry J; Cheilitis Granulomatosa treated with intralesional corticosteroids and anti-inflammatory agents. Journal of the American Academy of Dermatology. 2011 Sep; 65(3): e101-e102.